Susquehanna International Group, LLP Immunity Bio, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 418,057 shares of IBRX stock, worth $1.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

418,057

Previous 379,101 10.28%

Holding current value

$1.88 Million

Previous $2.4 Million 35.28%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.32 - $6.7 $129,333 - $261,005	38,956 Added 10.28%	418,057 $1.55 Million
Q2 2024 Aug 15, 2024	BUY	$4.82 - $9.15 $1.29 Million - $2.45 Million	267,713 Added 240.34%	379,101 $2.4 Million
Q1 2024 May 07, 2024	SELL	$3.23 - $6.17 $241,125 - $460,602	-74,652 Reduced 40.13%	111,388 $598,000
Q4 2023 Feb 14, 2024	SELL	$1.25 - $5.21 $339,490 - $1.41 Million	-271,592 Reduced 59.35%	186,040 $933,000
Q3 2023 Nov 14, 2023	BUY	$1.29 - $3.1 $125,670 - $301,998	97,419 Added 27.04%	457,632 $773,000
Q2 2023 Aug 11, 2023	SELL	$1.53 - $6.41 $114,688 - $480,493	-74,960 Reduced 17.23%	360,213 $1 Million
Q1 2023 May 16, 2023	BUY	$1.35 - $4.78 $17,784 - $62,971	13,174 Added 3.12%	435,173 $792,000
Q4 2022 Feb 14, 2023	SELL	$4.35 - $6.77 $908,136 - $1.41 Million	-208,767 Reduced 33.1%	421,999 $2.14 Million
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $204,571 - $360,382	56,047 Added 9.75%	630,766 $3.14 Million
Q2 2022 Aug 15, 2022	SELL	$2.68 - $6.14 $509,792 - $1.17 Million	-190,221 Reduced 24.87%	574,719 $2.14 Million
Q1 2022 May 16, 2022	SELL	$5.05 - $7.53 $931,654 - $1.39 Million	-184,486 Reduced 19.43%	764,940 $4.29 Million
Q4 2021 Feb 14, 2022	BUY	$5.67 - $10.18 $362,777 - $651,336	63,982 Added 7.23%	949,426 $5.77 Million
Q3 2021 Nov 15, 2021	BUY	$9.17 - $14.24 $1.1 Million - $1.71 Million	120,263 Added 15.72%	885,444 $8.62 Million
Q2 2021 Aug 11, 2021	BUY	$13.41 - $22.4 $3.96 Million - $6.61 Million	294,954 Added 62.73%	765,181 $10.9 Million
Q1 2021 May 17, 2021	BUY	$12.83 - $42.25 $6.03 Million - $19.9 Million	470,227 New	470,227 $11.2 Million

Others Institutions Holding IBRX

# of Institutions

202

Shares Held

70M

Call Options Held

1.68M

Put Options Held

1.31M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Immunity Bio, Inc. Transaction History